2. Lipids
  3. Fatty Esters
  4. Fatty Acid Estolides

Fatty Acid Estolides

Fatty Acid Estolides (22):

Cat. No. Product Name CAS No. Purity Chemical Structure
  • HY-120657
    9-PAHSA 1481636-31-0 99.88%
    9-PAHSA is an orally active endogenous GPR120 agonist (EC50=18 μM). 9-PAHSA significantly inhibits LPS-induced inflammatory responses by blocking the NF-κB pathway. 9-PAHSA induces adipocyte browning, enhances glucose uptake and reduces lipid accumulation, while improving mitochondrial function and the survival rate of steatotic hepatocytes. In terms of neuroprotection, 9-PAHSA regulates the expression of REST and BDNF in the prefrontal cortex of diabetic mice, and effectively prevents spatial working memory deficits and abnormal social behaviors. 9-PAHSA does not directly regulate insulin secretion or improve systemic insulin sensitivity, and possesses specific anti-inflammatory, metabolic regulatory and neuroprotective properties. 9-PAHSA can be used in the research of diabetes-related cognitive impairment, obesity and non-alcoholic fatty liver disease.
    9-PAHSA
  • HY-116193
    5-PAHSA 1481636-41-2 99.97%
    5-PAHSA increases insulin sensitivity, and has orally active anti-inflammatory and neuroprotective effects in mice HFD-induced diabetes mice. 5-PAHSA can be used for research of neurological dysfunction in diabetics.
    5-PAHSA
  • HY-117586
    9-PAHPA 1636134-70-7
    9-PAHPA is a fatty acid esters of hydroxy fatty acid (FAHFA). FAHFAs are a new family of endogenous lipids, have antidiabetic and anti-inflammatory effects.
    9-PAHPA
  • HY-158584
    13-OAHSA 1997286-67-5 99.00%
    13-OAHSA is one of fatty acid esters of hydroxy fatty acids (FAHFAs). 13-OAHSA increases glucose-stimulated insulin secretion (GSIS) at a high glucose concentration.
    13-OAHSA
  • HY-W709961
    5-OAHSA 1997286-66-4 99.9%
    5-OAHSA (1-(3-Carboxypropyl)tetradecyl (9Z)-9-octadecenoate) is a endogenous lipid. 5-OAHSA reduces the level of blood glucose, improves the glucose tolerance, and stimulates the the secretion of GLP-1 and insulin. 5-OAHSA exhibits potential in regulating metabolic and inflammatory responses.
    5-OAHSA
  • HY-131934
    9-OAHSA 154086-90-5 ≥99.0%
    9-OAHSA is a fatty acid ester of hydroxy fatty acids (FAHFAs). 9-OAHSA shows anti-inflammatory effects via inhibiting cytokine production and reduces IL-1β and IL-6 expression. 9-OAHSA is also a protective molecule to prevent colon carcinoma cells from apoptotic cell death.
    9-OAHSA
  • HY-131668
    9-POHSA 1481636-43-4 98.5%
    9-POHSA is a fatty acid ester of hydroxy fatty acids (FAHFAs). 9-POHSA shows anti-inflammatory effects via inhibiting cytokine production and reduces IL-1β and IL-6 expression.
    9-POHSA
  • HY-113878
    12-OAHSA 101901-73-9 99.0%
    12-OAHSA is a component of olive oil. 12-OAHSA has oral activity, and improves glucose homeostasis in insulin resistant obese mice.
    12-OAHSA
  • HY-158650
    10-OAHSA 2005487-34-1 99.0%
    10-OAHSA is one of fatty acid esters of hydroxy fatty acids (FAHFAs). 10-POHSA increases glucose-stimulated insulin secretion (GSIS) at a high glucose concentration. 10-OAHSA reduces LPS (HY-D1056)-induced Tnf-α secretion in bone marrow-derived dendritic cells (BMDCs).
    10-OAHSA
  • HY-158583
    13-POHSA 2126038-97-7 99.0%
    13-POHSA is one of fatty acid esters of hydroxy fatty acids (FAHFAs). 13-POHSA increases glucose-stimulated insulin secretion (GSIS) at a high glucose concentration.
    13-POHSA
  • HY-176829
    FAHFA 18:1(9Z)/32-O-32:1(25Z)
    FAHFA 18:1(9Z)/32-O-32:1(25Z) (OAHFA 18:1(n-9, cis)/ω-O-32:1(n-7, cis)) is an (O-acyl)-ω-hydroxy fatty acid (OAHFA) containing Oleic acid (HY-N1446) and 25(Z)-dotriacontenoic acid.
    FAHFA 18:1(9Z)/32-O-32:1(25Z)
  • HY-158639
    12-POHSA 2042646-31-9
    12-POHSA is one of fatty acid esters of hydroxy fatty acids (FAHFAs). 12-POHSA increases glucose-stimulated insulin secretion (GSIS) at a high glucose concentration.
    12-POHSA
  • HY-W769935
    5-POHSA 2161370-68-7
    5-POHSA, a fatty acid esters of hydroxy fatty acid (FAHFA), potentiates glucose transport.
    5-POHSA
  • HY-130434
    12-SAHSA 51350-61-9
    12-SAHSA is a fatty acid ester of hydroxy fatty acids (FAHFAs). 12-SAHSA decreases in the human serum of breast cancer.
    12-SAHSA
  • HY-130352
    9-SAHSA 1895916-79-6
    9-SAHSA is a fatty acid ester of hydroxy fatty acids (FAHFAs). 9-SAHSA is a protective molecule to prevent colon carcinoma cells from apoptotic cell death.
    9-SAHSA
  • HY-158625
    10(R)-PAHSA 2270844-02-3
    10(R)-PAHSA is a stereoisomer of 10-PAHSA, an endogenous lipid that belongs to a collection of branched fatty acid esters of hydroxy fatty acids (FAHFAs).
    10(R)-PAHSA
  • HY-158626
    10(S)-PAHSA 2270843-65-5
    10(S)-PAHSA is a stereoisomer of 10-PAHSA, an endogenous lipid that belongs to a collection of branched fatty acid esters of hydroxy fatty acids (FAHFAs).
    10(S)-PAHSA
  • HY-158597
    13-PAHSA 2169306-42-5
    13-PAHSA is an endogenous lipid that belongs to branched fatty acid esters of hydroxy fatty acids (FAHFAs)
    13-PAHSA
  • HY-158582
    13-SAHSA 2108907-29-3
    13-SAHSA is an endogenous lipid that belongs to branched fatty acid esters of hydroxy fatty acids (FAHFAs)
    13-SAHSA
  • HY-136796
    12-PAHSA 1997286-65-3
    12-PAHSA is a fatty ester.
    12-PAHSA